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Abstract
Whipple‘s disease is a rare systemic disorder classically 
presenting with weight loss, arthralgias, and diarrhea, 
which was first described in 1907. The causative bacterium 
Tropheryma whipplei, is a fastidious organism not growing on 
conventional media. Before the introduction of polymerase 
chain reaction (PCR)-based methods, the diagnostic gold 
standard was histological detection of diastase-resistant 
periodic acid Schiff (PAS)-positive macrophages or electron 
microscopy. As in the present case, contradictory results 
between the former and new diagnostic methods may 
obscure the correct diagnosis. We critically summarize the 
performance of the different diagnostic methods and discuss 
their impact on the clinical management of patients with 
suspected Whipple‘s disease.
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Introduction
Intestinal lipodystrophy was first recognized as a new disor-
der in 1907 by the pathologist George Hoyt Whipple [1]. The 
histological criteria for Whipple‘s disease as summarized in 
1949 were periodic acid Schiff (PAS)-positive inclusions 
detectable in macrophages of the intestines and mesenteric 
lymph nodes [2]. In 1991, the bacterium of Whipple’s dis-
ease was partially characterized at the molecular level by 
broad-range bacterial 16S rDNA PCR and sequencing [3]. 
Isolation of the bacterium was achieved in the late 1990s 
in long-term culture systems with interleukin-4-deactivated 
human primary macrophages [4] and fibroblasts [5] provid-
ing a basis for further characterization of the organism [6]. 
Since then the organism is officially named Tropheryma 
whipplei. It is a small, uniform, rod-shaped, gram-positive, 
not acid-fast bacterium measuring 0.2 X 1.5–2.0 µm in size 
[7, 8]. By transmission electron microscopy, the bacterial 
cell wall appears as a trilamellar structure. The analysis of 
its small (925 kb) single circular chromosome points to a 
host-restricted lifestyle and immune evasion as an impor-
tant role in the pathogenesis of the chronic course of Whip-
ple’s disease [9]. The modern molecular-based techniques 
greatly improved the diagnostic methods to recognize 
Whipple’s disease which is characterized by a great varia-
tion in clinical presentation [7, 8]. Untreated Whipple’s dis-
ease has a chronic progressive and potentially fatal course 
due to cardiac or central nervous system failure, wasting 
syndrome or septic shock [7, 8, 10, 11]. More than 90% 
of the patients respond to antibiotic therapy, but about 5 
to 30% relapse despite prolonged treatment [7, 8, 12, 13]. 
Difficulties occur for the clinicians when the results of the 
different methods are contradictory. Such conflicting re-
sults may lead to a false diagnosis and death of the patient, 
as the present case demonstrates.
Case Report
A 66-year-old man was admitted to the hospital because of recur-
rent fever, arthralgias, and exanthema. The patient had been well 
until 7 years earlier when polymyalgia rheumatica was diagnosed 
and was treated with prednisone and methotrexate. Two years 
before admission, intermittent episodes of fever with leukocyto-
sis and elevated C-reactive protein (CRP) levels occurred, which 
were successfully treated with amoxicillin. On admission the pa-
tient complained of weight loss, irregular bowel movements with 
constipation and diarrhea, polyarthralgias, pain and stiffness of 
the proximal limbs, sicca symptoms, pleuritic pain, and a pale 
patchy rash. Laboratory analysis showed anemia (hemoglobin 
11.8 g/dl), leukocytosis (22.8 X 109/l) with neutrophilia (97%) 
and lymphopenia (1.8%), and elevated inflammatory markers, 
i.e. blood sedimentation rate of 82 mm/h and CRP 76 mg/l. Cul-
tures from blood, urine, stool, and knee joint fluid did not reveal 
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a causative pathogen. Serum protein electrophoresis, immuno-
globulins, and serological tests for infections and autoantibodies 
were negative. Additional diagnostic procedures including bone 
marrow and skin biopsy, MR-angiography, echocardiography, 
positron emission tomography, and endoscopy were unremark-
able. PCR from the knee joint fluid and a duodenal biopsy by 
semi-nested amplification using the primer pairs TW1/TW2 and 
TW4/TW2 were positive for T. whipplei (Figure 1). However, 
broad-spectrum bacterial PCR using a 16S rRNA gene fragment 
as well as the confirmation by another T. whipplei-specific PCR 
using a different technique [14] performed on the same specimens 
were negative. Further investigation by histological examination 
of duodenal biopsies did not reveal PAS-positive macrophages. 
Therefore, Whipple’s disease was ruled out and a systemic in-
flammatory disorder of unknown origin was assumed. During the 
following 3 months, the patient was treated with indometacin and 
prednisone, but the clinical situation worsened and he died of 
multiorgan failure. Examination at autopsy revealed foamy mac-
rophages filled with diastase-resistant PAS-positive particles in 
the lamina propria of the small and large intestines, the myo- and 
pericardium (Figure 2), the skeletal muscles, the bone marrow, 
and the retroperitoneal soft tissue. Scanty PAS-positive granular 
inclusions were also detected in hippocampal ganglion cells, but 
not in the liver, spleen, and lymph nodes. The joints were not 
examined at autopsy. Reevaluation of the duodenal biopsies also 
showed a small number of PAS-positive macrophages. Based on 
these pathological findings a final postmortem diagnosis of Whip-
ple’s disease was made.
Discussion
Whipple’s disease is a systemic infection that may involve 
any major organ system. The leading symptoms of weight 
loss, arthropathy, and diarrhea are not specific. Thus, the 
clinical suspicion has to be confirmed by further diagnostic 
tests on specimens obtained from the distal duodenum, the 
jejunum or the site of clinical manifestation such as heart 
valves, lymph nodes, synovial tissue and cerebrospinal fluid 
(CSF). Even stool specimens may be used to demonstrate 
the presence of DNA for T. whipplei [15]. The histological 
hallmark is the presence of foamy macrophages staining 
purple with diastase-resistant PAS, whereas PAS stain-
ing alone is not completely specific. PAS-positive macro-
phages are also found in patients with infections caused 
by Mycobacterium avium-intracellulare, Rhodococcus equi, 
Bacillus cereus, Corynebacterium sp., Histoplasma capsula-
tum, or other fungi. Some of the histopathological features 
of Whipple’s disease are known also to occur in melano-
sis coli, histiocytosis, Crohn’s disease, and Waldenström’s 
macroglobulinemia [7, 8]. A further histological finding in 
lymphatic tissue, liver and the gastrointestinal tract asso-
ciated with Whipple’s disease are non-caseating, epithe-
loid-cell granulomas (sarcoid-like) [15]. Confusingly, the 
reactive macrophages present in these unspecific lesions 
are PAS-negative indicating that they do not contain T. 
whipplei.
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Figure 1. PCR from the knee joint fluid. Agarose gel electrophoresis 
of PCR products after semi-nested amplification using primer pairs 
TW1/TW2 (upper band, amplicon size 267bp) followed by TW4/TW2 
(lower band, amplicon size 229bp). Lane 1, positive control with a 
constructed plasmid; lane 2, negative control with a strain of Esche-
richia coli, passing the whole procedure of DNA extraction and PCR 
reaction; lane 3, joint fluid of patient, undiluted DNA extract; lane 4, 
joint fluid of patient, DNA extract diluted 1:5. The relative intensities 
of bands in lanes 3 and 4 indicate that the amplification was slightly 
inhibited when undiluted DNA extract was tested.
Figure 2. Pathological finding at autopsy: specimen of the myocar-
dium stained with periodic acid Schiff (PAS) and the specific diastase 
PAS (inset). Microscopic examination demonstrates multiple macro-
phages engorged with PAS-positive material (arrows) between the 
myocytes and in the interfibrillar connective tissue.
In addition, T. whipplei can be identified by electron 
microscopy in tissue samples from infected organs due to 
its unusual and highly specific trilamellar cell wall. How-
ever, electron microscopy is not a convenient method for 
rapid clinical diagnosis and data comparing its performance 
with other diagnostic methods in Whipple’s disease are not 
available. Therefore, electron microscopy is primarily used 
in questionable cases [7, 8].
Since the sequencing of the 16S rDNA gene and the 
description of specific primers for T. whipplei, gene am-
plification with PCR has been introduced as a diagnostic 
tool. However, clinicians have to be aware of several dif-
ferent factors influencing the performance of PCR. Na-
tive clinical specimens give better results as compared to 
formalin-fixation tissue due to partial degradation of the 
DNA [7]. Moreover, DNA extraction which is one of the 
crucial steps of all PCR techniques has to be adapted for 
particular clinical samples especially for those contain-
ing inhibitors of the Taq polymerase (e.g. feces) [7, 16]. 
Amplification with semi-nested and nested methods is as-
sociated with a higher risk for contamination, which can 
be reduced by using at least two independent PCR tests 
based on different target genes [8]. The sensitivity of these 
molecular tests also depends on the target gene and the 
length of the amplified fragments [7]. Specimens suitable 
for PCR are duodenal-biopsy tissue, lymph nodes, heart 
valves, vitreous humor, stool, and synovial or cerebrospi-
nal fluid [8]. PCR may also be positive in samples from 
the sites of clinical manifestations of Whipple’s disease, 
e.g. from a disc biopsy in a patient with spondylodisci-
tis or from joint fluid as in the present case [7, 12, 17]. 
However, it is currently impossible to detect T. whipplei 
DNA reproducibly from peripheral blood samples in pa-
tients with proven disease [7, 18]. On the other hand, T. 
whipplei was amplified from saliva, dental plaque, gastric 
juice, duodenal-biopsy samples, and feces in 4 to 35 % 
of healthy persons and patients without Whipple’s dis-
ease [14, 16, 19–22], indicating that the diagnostic value 
of these specimens is limited in patients with a low clinical 
pretest probability. 
Due to the rareness of Whipple’s disease, quantitative 
comparative assessment of the different diagnostic meth-
ods is limited by the lack of studies directly addressing 
this question in a sufficient number of patients. Currently, 
there is no diagnostic gold standard conclusively defin-
ing Whipple’s disease. Therefore, analyzing all published 
cases of Whipple’s disease collected by Dutly and Altwegg 
[7], as well as data reported in more recent studies [14, 
16, 19–23], we calculated the sensitivity and specificity 
of PCR and histology to detect Whipple’s disease (Table 
1). In gastrointestinal samples the sensitivity of PCR and 
histology were similar. In contrast, PCR techniques had a 
higher sensitivity than the presence of PAS-positive mac-
rophages in histological evaluations of specimens from 
involved organs. The specificity of PCR was limited by 
false-positive results on saliva, dental plaque, and gastro-
intestinal samples in patients without Whipple’s disease. 
As mentioned above, histological results showing the 
presence of macrophages with PAS-positive inclusions 
are not specific for Whipple’s disease; however quantita-
tive data on this issue are not available. 
In conclusion, untreated Whipple’s disease has a 
chronically progressive and potentially fatal course. 
However, most patients respond to antibiotic treatment 
with ceftriaxone, trimethoprim-sulfomethoxazole, or tet-
racycline resulting in rapid improvement of the clinical 
status and lasting remissions [7, 8, 12, 13]. Therefore, in 
cases of contradictory results between the former gold 
standard, PAS staining of duodenal biopsies, and recently 
introduced, highly sensitive PCR techniques, antibiotic 
treatment is warranted. In addition, critically reviewing 
the diagnostic results including meticulous reevaluation 
of all specimens and repeated sampling may help to find 
the correct diagnosis.
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Samples from                             Gastrointestinal tract                                                 Involved organs
 Histology   PCR   Histology   PCR   
Sensitivity (95% CI) 78% (71–85)a 84% (71–92)b 79% (64–90)c 100% (87–100)d
Specificity (95% CI) NA 94% (92–95)e NA NA
Histology: detection of periodic acid Schiff (PAS)-positive macrophages; PCR: polymerase chain reaction with different primers and tech-
niques; CI: confidence interval; NA: not available. Sensitivity and specificity including exact 95% binominal confidence intervals were 
calculated using the patients published in the references [14, 16, 19–23]. Patients redundantly described in more than one reference were 
counted only once. a Biopsies from the gastrointestinal tract were diagnostic in 123 of 157 patients with intestinal or extraintestinal mani-
festations of Whipple‘s disease. b PCR from gastrointestinal samples (biopsies, gastric juice, stool, saliva) was positive in 46 of 55 patients 
with intestinal or extraintestinal manifestations of Whipple‘s disease. c Biopsies from involved extraintestinal organs were diagnostic in 
34 of 43 patients with Whipple‘s disease. d PCR from involved extraintestinal organs was positive in 27 of 27 patients with Whipple‘s dis-
ease. e PCR from gastrointestinal samples (biopsies, gastric juice, stool, saliva, dental plaque) was positive in 60 of 970 patients without 
Whipple‘s disease
Table 1
Evaluation of histology and polymerase chain reaction for Whipple‘s disease.
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